Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06085352 · ClinicalTrials.gov registry record · Early Phase 1
Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure
A Early Phase 1 study, sponsored by Vance Thompson Vision.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT06085352 is a Early Phase 1 study that has completed, run by Vance Thompson Vision. The registered enrollment target is 10 participants.
The verdict
NCT06085352, a Early Phase 1 study, has completed, sponsored by Vance Thompson Vision.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine the safety, efficacy, and comfort of the investigational TetraLens bandage contact lens in patients who have undergone photorefractive keratectomy (PRK). The main question\[s\] it aims to answer are: * Understand benefit of managing pain following the surgical procedure * Understand the safety of the Tetralens Participants will be asked to wear theTetraLens BCL in one eye for 6 days post-operatively and: document the daily quantity of oral analgesics needed and report ocular pain and contact lens comfort. Researchers will compare the study lens in one eye to a control lens in the contralateral (other eye)
Interventions
- DRUG TetraLens bandage contact lens
- DEVICE Control Acuvue Oasys Bandage contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-06-26 |
| Est. Completion | 2024-01-25 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06085352
The ClinicalTrials.gov registry entry for NCT06085352 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TetraLens bandage contact lens is the first listed.
NCT06085352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06085352 about?
NCT06085352 is a clinical study titled "Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure". The goal of this clinical trial is to determine the safety, efficacy, and comfort of the investigational TetraLens bandage contact lens in patients who have undergone photorefractive keratectomy (PRK). The main question\[s\] it aims to answer are: * Understand benefit of managing pain following the...
What is the current status of trial NCT06085352?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2023-06-26. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT06085352?
The interventions under investigation include: TetraLens bandage contact lens (DRUG), Control Acuvue Oasys Bandage contact Lens (DEVICE).
Who is sponsoring clinical trial NCT06085352?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.